Currently, several objective indicators, such as Angiotensin II and aldosterone [9], may be helpful for clinical management of hypertension, but it is necessary to continue to explore the novel biomarkers or clinical indexes for prediction or diagnosis of hypertension among reproductive-aged women. This evidence concerns the gene AGT and Hypertension.